Navigation Links
Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever

The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

The contract will include collaboration between Tulane; Scripps Research Institute; The Broad Institute; Harvard University; the University of California at San Diego; Boston University; Autoimmune Technologies, LLC; Corgenix Medical Corporation and various partners in West Africa.

Dr. James Robinson, professor of pediatrics at Tulane University School of Medicine and principal investigator of the program, said researchers plan to evaluate antibodies from patients who were infected by the Lassa virus and recovered, to see if those antibodies might play a role in the development of a vaccine or treatment for the illness.

"This study will result in a fundamental understanding of the mechanisms of antibody responses and how they neutralize the Lassa virus," Robinson said. "We have assembled a very strong and diverse group of institutions to collaborate on this project."

In some areas of Sierra Leone, up to 16 percent of people admitted to hospitals have Lassa fever. Lassa fever is also associated with occasional epidemics, during which the fatality rate can reach 50 percent.

But Dr. Robert Garry, professor of microbiology and immunology at Tulane, who serves as program manager of the contract, sees hope.

"We have been very pleased with the results of our research efforts over the past five years," he said. "The diagnostic products we have developed have been shown to be remarkably effective in clinical settings in Africa, and will not only have a meaningful impact on health care in that part of the world, but will also fill a critical gap in bioterrorism defense. Now under the new NIH award, we will move to the next level allowing us to better treat the disease, or ultimately prevent it altogether."

Another team member, Dr. Daniel Bausch, associate professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine, says that the group intends to expand this program to address other important infectious agents such as Ebola, Marburg and other hemorrhagic fever viruses that are of concern to the public health and bioterrorism preparedness communities.


Contact: Arthur Nead
Tulane University

Related biology news :

1. Tulane receives grant to study limb regeneration
2. Carnegie Mellons John Kitchin receives early career award
3. Jedi Mind Receives Vast Media Coverage at CES in Las Vegas
4. University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium
5. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
6. Editor of Springer classic human genetics reference receives prize
7. Lehigh University professor receives Astellas Award for arsenic groundwater remediation efforts
8. University of California, San Francisco, researcher receives ASBMB-Merck Award
9. IGC scientist receives prestigious EMBO installation grant
10. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
11. Einstein receives high-risk/high-reward cancer research funding
Post Your Comments:
(Date:11/10/2015)... 2015 About signature verification ... to identify and verify the identity of an ... the secure and accurate method of authentication and ... individual because each individual,s signature is highly unique. ... dynamic signature of an individual is compared and ...
(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... , Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ... Dr. Norman C.W. Wong to its Board of ... comes to Zenith with a wealth of experience as co-founder ... molecular biology. --> --> ... Zenith Epigenetics, board of directors. Zenith,s long standing expertise in ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
(Date:11/30/2015)... 2015  AbbVie, is introducing Good Morning Hypothyroidism ... daily routine for managing the life-long condition of hypothyroidism. ... the way the body absorbs it so resources encouraging ... routine are important. The goal of the new website ... their hypothyroidism by establishing a daily routine, spirit of ...
(Date:11/30/2015)... Israel , Nov. 30, 2015 ... leading developer of adult stem cell technologies for neurodegenerative diseases, ... has been awarded an additional grant of approximately $735,000 from ... (OCS). This grant, the second this year, brings the total ... $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology: